Предиктори виникнення серцево-судинних подій у пацієнтів з тріпотінням передсердь при тривалому спостереженні

А.В. Акер, У.П. Черняга-Ройко, Н.С. Павлик, О.Й. Жарінов

Література  

1. Zalizna YuI, Mikhalev KO, Zharinov OJ. Predictors of arrhythmia recurrence after the first episode of atrial fibrillation during 6-months follow-up. Ukr Cardiol J. 2017;6:68–78. (in Ukr.).
2. Al-Kawaz M, Omran S, Parikh N, Elkind M, Soliman EZ, Kamel H. Comparative risks of ischemic stroke in atrial flutter versus atrial fibrillation. J Stroke Cerebrovasc Dis. 2018;27(4):839–844. doi:10.1016/j.jstrokecerebrovasdis.2017.10.025.
3. Brembilla-Perrot В, Ferreira J, Manenti V, Sellal JM, Olivier A, Villemin T, Beurrier D, De Chillou C, Louis P, Brembilla A, Juillière Y, Girerd N. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation. Eur J Heart Fail. 2016;18(4):394–401. doi: 10.1002/ejhf.482.
4. Brembilla-Perrot B, Girerd N, Sella JM, Olivier A, Manenti V, Villemin T, Beurrier D, de Chillou C, Louis P, Selton O, de la Chaise AT. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication. J Cardiovasc Electrophysiol. 2014;25(8):813–820. doi: 10.1111/jce.12413.
5. Chao Tze-Fan, Fauchier L. Stroke prevention in patients with atrial flutter. Europace. 2019;21(2):186–187. doi: 10.1093/europace/euy197.
6. Chen Y-L, Lin Y-S, Wang H-T, Liu WH, Chen HC, Chen MC. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study. Europace. 2019;21:313–321. doi:10.1093/europace/euy181.
7. De Loma-Osorio F, Diaz-Infante E, Gallego M. Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012). Rev Esp Cardiol (Engl. Ed.). 2013;66:983–992. doi: 10.1016/j.rec.2013.08.002.
8. Glover B, Chen J, Hong K, Boveda S, Baranchuk A, Haugaa KH, Dorian P, Potpara TS, Crystal E, Mitchell B, Tilz R, Leong-Sit P, Dagres N. Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society. Europace. 2016;18(12):1880–1885. doi: 10.1093/europace/euw402.
9. Granada J, Uribe W, Chyou P, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol. 2000;36:2242–2246. doi: 10.1016/s0735-1097(00)00982-7.
10. Huxley R, Lopez F, Folsom A, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501–1508. doi: 10.1161/circulationaha.110.009035.
11. Kafkas N, Patsilinakos S, Mertzanos G, Papageorgiou KI, Chaveles JI, Dagadaki OK, Kelesidis KM. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Intern J Cardiology. 2007;118(3):321–325. doi: 10.1016/j.ijcard.2006.07.017.
12. Kirchhof P, Benussi S, Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962. doi:10.1093/ejcts/ezw313.
13. Lin Y, Chen T, Chi C, Lin MS, Tung TH, Liu CH, Chen YL, Chen MC. Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter-a View From a National Cohort Study. J Am Heart Assoc. 2017;6(7):2047–9980. doi: 10.1161/JAHA.117.006406.
14. Luchsinger J, Steinberg J. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol. 1988;32(1):205–210. doi:10.1016/s0735-1097(98)00183-1.
15. Page R, Joglar J, Caldwell M. et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. J Am Coll Cardiol. 2016;67(13):1575–1623. doi:10.1161/CIR.0000000000000311.
16. Pérez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2(4):393–401. doi:10.1161/circep.109.871665.
17. Peyrol M, Sbragia P, Bonello L, Lévy S, Paganelli F. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation. Arch Cardiovasc Diseases. 2011;104(10):530–535. doi: 10.1016/j.acvd.2011.07.003.
18. Rahman F, Wang N, Yin X, Ellinor PT, Lubitz SA, LeLorier PA, McManus DD, Sullivan LM, Seshadri S, Vasan RS, Benjamin EJ, Magnani JW. Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm. 2016;13(1):233–240. doi: 10.1016/j.hrthm.2015.07.031.
19. Savarese G, Lund L. Global Public Health Burden Of Heart Failure. Cardiac Failure Review. 2017;3(1):7–11. doi: 10.15420/cfr.2016:25:2.
20. Vadmann H, Gorst-Rasmussen A, Hjortshøj SP, Riahi S, Lip GYH, Larsen TB. Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study. Europace. 2017;19(5):838–842. doi:10.1093/europace/euw107. 

[PDF] [Зміст журналу]